Forum

Case-Based Debate: Is Active Surveillance valid Option for 57 Year Old Patient with Recurrent TaLG Tumors, Small Size, Negative Cytology?

Moderator(s)

• 

  Mark S. Soloway, MD

  urologic oncology
  Memorial Hospital, Hollywood, FL

Debater-Pro(s)

• 

  Wes Kassouf, MD (he/him/his)

  Professor of Urology
  McGill University

Debater-Con(s)

• 

  Juan Palou, MD (he/him/his)

  Fundacio Puigvert. Universitat Autònoma de Barcelona. Barcelona